Business Description
Xiamen Amoytop Biotech Co Ltd
ISIN : CNE100003RT3
Share Class Description:
SHSE:688278: Class ACompare
Compare
Traded in other countries / regions
688278.China IPO Date
2020-01-17Description
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 87.08 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 1463.66 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 34.61 | |||||
| Beneish M-Score | -2.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 37.9 | |||||
| 3-Year EBITDA Growth Rate | 56.9 | |||||
| 3-Year EPS without NRI Growth Rate | 73.9 | |||||
| 3-Year Book Growth Rate | 23.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.46 | |||||
| 9-Day RSI | 36.73 | |||||
| 14-Day RSI | 36.9 | |||||
| 6-1 Month Momentum % | 24.76 | |||||
| 12-1 Month Momentum % | 35.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.84 | |||||
| Quick Ratio | 3.22 | |||||
| Cash Ratio | 1.89 | |||||
| Days Inventory | 452.03 | |||||
| Days Sales Outstanding | 57.1 | |||||
| Days Payable | 143.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.76 | |||||
| Dividend Payout Ratio | 0.14 | |||||
| 3-Year Dividend Growth Rate | 104.2 | |||||
| Forward Dividend Yield % | 0.76 | |||||
| 5-Year Yield-on-Cost % | 0.77 | |||||
| Shareholder Yield % | 0.77 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 93.71 | |||||
| Operating Margin % | 33.07 | |||||
| Net Margin % | 26.95 | |||||
| FCF Margin % | 10.81 | |||||
| ROE % | 34.94 | |||||
| ROA % | 28.23 | |||||
| ROIC % | 49.37 | |||||
| ROC (Joel Greenblatt) % | 101.47 | |||||
| ROCE % | 38.46 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 36.05 | |||||
| PE Ratio without NRI | 35.38 | |||||
| Price-to-Owner-Earnings | 49.26 | |||||
| PEG Ratio | 0.63 | |||||
| PS Ratio | 9.7 | |||||
| PB Ratio | 10.82 | |||||
| Price-to-Tangible-Book | 13.14 | |||||
| Price-to-Free-Cash-Flow | 90.16 | |||||
| Price-to-Operating-Cash-Flow | 38.15 | |||||
| EV-to-EBIT | 30.32 | |||||
| EV-to-EBITDA | 30.32 | |||||
| EV-to-Revenue | 9.46 | |||||
| EV-to-FCF | 89.68 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.42 | |||||
| Price-to-Graham-Number | 4.55 | |||||
| Price-to-Net-Current-Asset-Value | 23.72 | |||||
| Price-to-Net-Cash | 93.61 | |||||
| Earnings Yield (Greenblatt) % | 3.3 | |||||
| FCF Yield % | 1.11 | |||||
| Forward Rate of Return (Yacktman) % | 20.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Xiamen Amoytop Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,226.317 | ||
| EPS (TTM) (Â¥) | 1.48 | ||
| Beta | 0.54 | ||
| Volatility % | 39.61 | ||
| 14-Day RSI | 36.9 | ||
| 14-Day ATR (Â¥) | 1.833334 | ||
| 20-Day SMA (Â¥) | 56.018 | ||
| 12-1 Month Momentum % | 35.13 | ||
| 52-Week Range (Â¥) | 31.01 - 69.97 | ||
| Shares Outstanding (Mil) | 406.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Xiamen Amoytop Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Xiamen Amoytop Biotech Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Xiamen Amoytop Biotech Co Ltd Frequently Asked Questions
What is Xiamen Amoytop Biotech Co Ltd(SHSE:688278)'s stock price today?
The current price of SHSE:688278 is ¥53.36. The 52 week high of SHSE:688278 is ¥69.97 and 52 week low is ¥31.01.
When is next earnings date of Xiamen Amoytop Biotech Co Ltd(SHSE:688278)?
The next earnings date of Xiamen Amoytop Biotech Co Ltd(SHSE:688278) is .
Does Xiamen Amoytop Biotech Co Ltd(SHSE:688278) pay dividends? If so, how much?
The Dividend Yield %  of Xiamen Amoytop Biotech Co Ltd(SHSE:688278) is 0.76% (As of Today), Highest Dividend Payout Ratio of Xiamen Amoytop Biotech Co Ltd(SHSE:688278) was 0.15. The lowest was 0.09. And the median was 0.11. The  Forward Dividend Yield % of Xiamen Amoytop Biotech Co Ltd(SHSE:688278) is 0.76%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers